At Episode One Laboratories, we are committed to providing robust recombinant protein and assay development services to drive breakthroughs in high-throughput screening and DNA-encoded library (DEL) technologies. Our mission is to be the premier partner for our clients seeking recombinant protein production and biochemical assay development services so they can accelerate their drug discovery initiatives with confidence. From our Boston headquarters, our team of experienced Scientists works diligently to provide the highest quality reagents while delivering them promptly and efficiently - making it easier than ever for researchers looking to uncover life-saving treatments.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 57 Smith Pl, Cambridge,massachusetts 02138,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://episode1labs.com/
- HQ
- Cambridge, Massachusetts
Episode One Laboratories Questions
Episode One Laboratories's website is http://episode1labs.com/
Episode One Laboratories's LinkedIn profile is https://www.linkedin.com/company/episode-one-laboratories
Episode One Laboratories has
1 employees.
View email and phone details for 1
employees at Episode One Laboratories.
Episode One Laboratories's industry is
Biotechnology Research
Episode One Laboratories's top competitors are
Dojindo Molecular Technologies, Inc.,
Diagnostic Reagents,
Angio-Proteomie,
Cheminpharma,
Ab Biosciences,
Transomic Technologies Inc.,
Alphabioregen, Inc.,
Enfanos, Llc.,
Captivate Bio,
Tenova Pharma.
Episode One Laboratories's categories are Biotechnology Research
Episode One Laboratories's founding year is 2022
